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Abstract 
Short communication on succinate dehydrogenase-
deficient renal cell carcinoma. 
Keywords 
Kidney; Renal cell carcinoma 
Identity 
Other names 
Kidney: SDH-deficient renal cell carcinoma 
Clinics and pathology 
Epidemiology 
Succinate dehydrogenase-deficient renal cell 
carcinoma represents between 0.05 and 0.2% of all 
renal cell carcinoma (RCCs) and is found in young 
adults. Mean patient age at presentation was 37 
years (range, 14 to 76 y), with a slight male 
predominance (M:F=1.7:1). 
Clinics 
Bilateral tumors were observed in 26% of patients. 
Patients with germ line mutations in  succinate 
dehydrogenase deficient (SDH) subunit genes 
(SDHA ,B,C and D) are highly sensitive to certain 
types of neoplasms such as paragangliomas, 
pheochromocytomas, gastrointestinal stromal 
tumorsand renal cell carcinomas (Gill AJ .2012). 
Pathology 
Tumors have a tan to light brown well 
circumscribed cut surface. SDH-deficient RCC 
cells are comprised of a monomorphic population  
of eosinophilic, typically low grade tumor cells that 
have a bubbly appearance due to the presence of 
cytoplasmic vacuoles (abnormal mitochondria 
secondary to the SDH mutation); the latter may be 
lost in higher-grade transformed tumors. 
Immunohistochemistry All cases with the typical 
morphology demonstrated negative staining for 
SDHB.  
The presence of negative staining for SDHB almost 
always signifies germline mutation of one of the 
components of the mitochondrial complex 2 
(SDHA, SDHB, SDHC, SDHD, SDHAF2) 
Prognosis 
Sarcomatoid changes and necrosis are rare but are 
associated with poorer outcomes. 
Genetics 
Two hit process  
The two hit process (germ line mutations and loss 
of the wild-type allele) is involved in the 
development of SDHB-deficient renal cell 
carcinoma (Schmidt and Linehan 2016). 
The risk of renal tumors seems highest for SDHB 
mutation.  
The germ line mutations reported were extensively 
found in exons coding the mitochondrial targeting 
sequence or 2FE-2S ferredoxin-type iron-sulfur 
binding domain.  
Next-generation sequencing data Additionally, a 
targeted next-generation sequencing panel did not 
reveal alterations in other key genes involved in 
RCC pathogenesis, such as VHL, PIK3CA, AKT, 
MTOR, MET, or TP53 (Williamson et al. 2015). 
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Genes involved and 
proteins 
Succinate dehydrogenase (SDH) 
genes; SDHA, SDHB, SDHC, SDHD, 
SDHAF2. 
Succinate dehydrogenase (SDH) is a key 
respiratory enzyme complex that converts succinate 
to fumarate in the citric acid cycle (CAC) and also 
functions in the mitochondrial electron transport 
chain.  
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